Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

MARIBAVIR vs MAVACAMTEN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

MARIBAVIR vs MAVACAMTEN: Safety Overview

Metric MARIBAVIR MAVACAMTEN
Total FAERS Reports 1,923 3,250
Deaths Reported 386 79
Death Rate 20.1% 2.4%
Hospitalizations 893 454
Average Patient Age 54.8 yrs 66.6 yrs
% Female Patients 44.2% 69.1%
FDA Approval Date Nov 23, 2021 Apr 28, 2022
Manufacturer Takeda Pharmaceuticals America, Inc. Myokardia, Inc.
Route ORAL ORAL
Marketing Status Prescription Prescription